Application of biomaterials and nanotechnology in corneal tissue engineering.


Journal

The Journal of international medical research
ISSN: 1473-2300
Titre abrégé: J Int Med Res
Pays: England
ID NLM: 0346411

Informations de publication

Date de publication:
Jul 2023
Historique:
medline: 2 8 2023
pubmed: 31 7 2023
entrez: 31 7 2023
Statut: ppublish

Résumé

Corneal diseases are among the most common causes of blindness worldwide. Regardless of the etiology, corneal opacity- or globe integrity-threatening conditions may necessitate corneal replacement procedures. Several procedure types are currently available to address these issues, based on the complexity and extent of injury. Corneal allograft or keratoplasty is considered to be first-line treatment in many cases. However, a significant proportion of the world's population are reported to have no access to this option due to limitations in donor preparation. Thus, providing an appropriate, safe, and efficient synthetic implant (e.g., artificial cornea) may revolutionize this field. Nanotechnology, with its potential applications, has garnered a lot of recent attention in this area, however, there is seemingly a long way to go. This narrative review provides a brief overview of the therapeutic interventions for corneal pathologies, followed by a summary of current biomaterials used in corneal regeneration and a discussion of the nanotechnologies that can aid in the production of superior implants.

Identifiants

pubmed: 37523589
doi: 10.1177/03000605231190473
pmc: PMC10392709
doi:

Substances chimiques

Biocompatible Materials 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3000605231190473

Références

Biomaterials. 2018 Jul;171:57-71
pubmed: 29684677
Br J Ophthalmol. 1995 Sep;79(9):825-9
pubmed: 7488601
Acta Biomater. 2014 Mar;10(3):1167-76
pubmed: 24374324
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Jan-Feb;8(1):160-74
pubmed: 26109528
J Craniofac Surg. 2020 Mar/Apr;31(2):e194-e199
pubmed: 31977683
Colloids Surf B Biointerfaces. 2018 Apr 1;164:340-346
pubmed: 29413615
Nanomedicine (Lond). 2010 Jul;5(5):807-20
pubmed: 20662650
Ophthalmol Ther. 2019 Mar;8(1):5-17
pubmed: 30694513
Mol Vis. 2012;18:1068-73
pubmed: 22605919
Eye (Lond). 2012 Mar;26(3):418-25
pubmed: 22173079
J Funct Biomater. 2015 Feb 17;6(1):77-80
pubmed: 25695336
Exp Eye Res. 2018 Dec;177:122-129
pubmed: 30086260
Vision Res. 2008 Feb;48(3):319-24
pubmed: 17825344
PLoS One. 2014 Nov 11;9(11):e111503
pubmed: 25386892
JAMA Ophthalmol. 2016 Feb;134(2):167-73
pubmed: 26633035
Acta Ophthalmol. 2013 Sep;91(6):e432-6
pubmed: 23406295
Cornea. 2018 Feb;37(2):151-155
pubmed: 29135707
J Pharmacol Sci. 2007 Nov;105(3):215-28
pubmed: 17986813
PLoS One. 2018 Feb 6;13(2):e0192381
pubmed: 29408907
Am J Ophthalmol. 2011 May;151(5):829-839.e1
pubmed: 21310387
Acta Ophthalmol. 2008 Nov;86(7):708-15
pubmed: 18937825
Clin Ophthalmol. 2020 Apr 29;14:1189-1200
pubmed: 32425503
Biomol Concepts. 2020 Dec 31;11(1):182-200
pubmed: 34233430
Cornea. 2016 Sep;35(9):1165-74
pubmed: 27191675
Ophthalmology. 2016 Jan;123(1):165-77
pubmed: 26545318
ACS Macro Lett. 2012 Jul 17;1(7):876-881
pubmed: 35607136
Cornea. 2014 Sep;33(9):981-4
pubmed: 25014141
Exp Eye Res. 2018 Aug;173:188-193
pubmed: 29772228
Cornea. 2018 Jan;37(1):3-10
pubmed: 28990994
Am J Ophthalmol. 2013 Nov;156(5):867-873.e2
pubmed: 23958700
Curr Opin Biotechnol. 2016 Aug;40:103-112
pubmed: 27043763
Front Med (Lausanne). 2021 Nov 12;8:770780
pubmed: 34869489
Nanomaterials (Basel). 2018 Apr 30;8(5):
pubmed: 29710848
Stem Cells. 2012 Jun;30(6):1059-63
pubmed: 22489057
Biomech Model Mechanobiol. 2018 Feb;17(1):19-29
pubmed: 28780705
Acta Biomater. 2019 Aug;94:585-596
pubmed: 31129362
J Ophthalmol. 2018 Apr 19;2018:9580292
pubmed: 29850220
Br J Ophthalmol. 2015 Dec;99(12):1664-8
pubmed: 26034079
Adv Healthc Mater. 2012 Jul;1(4):393-412
pubmed: 23184771
Cells. 2021 Mar 20;10(3):
pubmed: 33804633
Retina. 2013 Mar;33(3):532-41
pubmed: 23073339
Front Bioeng Biotechnol. 2019 Jun 11;7:135
pubmed: 31245365
Tsitologiia. 1968 May;10(5):557-67
pubmed: 4885074
Ophthalmology. 2009 Apr;116(4):640-51
pubmed: 19243830
Am J Ophthalmol. 2007 Aug;144(2):227-231
pubmed: 17543875
Ocul Surf. 2018 Jul;16(3):272-281
pubmed: 29597010
Cornea. 2001 Jan;20(1):19-23
pubmed: 11188997
Ann Biomed Eng. 2015 Mar;43(3):657-80
pubmed: 25537688
Ophthalmic Plast Reconstr Surg. 2012 Sep-Oct;28(5):346-9
pubmed: 22820446
Ophthalmology. 1995 Apr;102(4):576-85
pubmed: 7724175
Arch Ophthalmol. 2002 May;120(5):559-66
pubmed: 12003604
Bioengineering (Basel). 2023 Jan 12;10(1):
pubmed: 36671683
Biochim Biophys Acta. 2001 Dec 5;1568(2):118-28
pubmed: 11750759
Nano Lett. 2010 Sep 8;10(9):3223-30
pubmed: 20726522
Ophthalmology. 2012 May;119(5):951-5
pubmed: 22361316
Sci Rep. 2017 Sep 4;7(1):10344
pubmed: 28871135
J Biomed Mater Res B Appl Biomater. 2016 Feb;104(2):431-41
pubmed: 25891207
Biomaterials. 2009 Mar;30(7):1299-308
pubmed: 19059642
J Mater Sci Mater Med. 2007 Apr;18(4):635-40
pubmed: 17546425
J Mol Histol. 2013 Oct;44(5):609-18
pubmed: 23636607
Ocul Immunol Inflamm. 2010 Aug;18(4):275-80
pubmed: 20662659
Exp Eye Res. 2010 Sep;91(3):326-35
pubmed: 20599432
Arch Ophthalmol. 2001 Apr;119(4):484-9
pubmed: 11296013
ACS Appl Nano Mater. 2021 Nov 26;4(11):12650-12662
pubmed: 35252778
Bull World Health Organ. 2001;79(3):214-21
pubmed: 11285665
J Cell Biol. 2000 Jun 12;149(6):1167-70
pubmed: 10851014
J Mater Sci Mater Med. 2015 Feb;26(2):107
pubmed: 25665845
ACS Appl Mater Interfaces. 2016 Jun 22;8(24):15160-8
pubmed: 27243449
Retina. 2008 Oct;28(8):1138-45
pubmed: 18779721
Ophthalmology. 2000 Apr;107(4):719-24
pubmed: 10768334
Tissue Eng Part C Methods. 2010 Apr;16(2):319-27
pubmed: 19563255
Br J Ophthalmol. 1996 Jun;80(6):532-5
pubmed: 8759264
Expert Rev Med Devices. 2011 Sep;8(5):607-26
pubmed: 22026626
Int J Nanomedicine. 2006;1(1):15-30
pubmed: 17722259
J Biomed Mater Res A. 2012 Feb;100(2):527-35
pubmed: 22140085
Nanomaterials (Basel). 2018 Feb 24;8(2):
pubmed: 29495264
Nanoscale. 2013 Feb 21;5(4):1273-83
pubmed: 23166050
Cornea. 2013 Jul;32(7):956-61
pubmed: 23538625
Biomaterials. 2014 Mar;35(8):2420-7
pubmed: 24374070
Curr Opin Ophthalmol. 2016 Jul;27(4):358-66
pubmed: 27054815
J Biomater Sci Polym Ed. 2019 Dec;30(17):1604-1619
pubmed: 31438806
Ophthalmology. 2014 Nov;121(11):2159-64
pubmed: 25017414
Cornea. 2014 Sep;33(9):905-9
pubmed: 25055151
Acta Biomater. 2017 Dec;64:346-356
pubmed: 29030302
Acta Biomater. 2013 Mar;9(3):5511-20
pubmed: 23131386
Cureus. 2020 Mar 23;12(3):e7374
pubmed: 32328385
Prog Retin Eye Res. 2013 Sep;36:172-98
pubmed: 23603534
Biomaterials. 2017 Mar;120:139-154
pubmed: 28061402
Cornea. 2015 Nov;34(11):1387-94
pubmed: 26382898
J Tissue Eng. 2019 Jan 25;10:2041731418823382
pubmed: 30719272
J Control Release. 2021 Apr 10;332:460-492
pubmed: 33675876
Cells Tissues Organs. 2013;198(3):190-7
pubmed: 24247045
Eye (Lond). 2021 Nov;35(11):3110-3115
pubmed: 33469134
Stem Cells. 2005 Oct;23(9):1266-75
pubmed: 16051989
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES192-DES199
pubmed: 30481826
Curr Ophthalmol Rep. 2016 Sep;4(3):147-153
pubmed: 28529825
Tissue Eng Part B Rev. 2014 Dec;20(6):683-96
pubmed: 24923709
Ann Biomed Eng. 2006 Jan;34(1):89-101
pubmed: 16525765
Biomaterials. 2010 Jan;31(3):461-6
pubmed: 19819008
Indian J Ophthalmol. 2020 Jan;68(1):185-186
pubmed: 31856506
Expert Rev Med Devices. 2006 Nov;3(6):835-51
pubmed: 17280547
Int Ophthalmol. 2018 Jun;38(3):1225-1233
pubmed: 28602017
Int Ophthalmol Clin. 2017 Summer;57(3):75-86
pubmed: 28590282
Acta Biomater. 2020 Apr 15;107:299-312
pubmed: 31978623
Cornea. 2009 Apr;28(3):321-7
pubmed: 19387235
J Mech Behav Biomed Mater. 2013 May;21:185-94
pubmed: 23566770
Biomaterials. 2006 Sep;27(26):4608-17
pubmed: 16713624
Am J Ophthalmol. 2012 Aug;154(2):266-271.e1
pubmed: 22633347
Am J Ophthalmol. 2008 Mar;145(3):438-44
pubmed: 18207122
Am J Ophthalmol. 2013 May;155(5):814-22
pubmed: 23352344
Biotechnol Adv. 2008 Jan-Feb;26(1):1-21
pubmed: 17884325
J Biomed Mater Res B Appl Biomater. 2018 Aug;106(6):2157-2168
pubmed: 29024376
Acc Chem Res. 2011 Oct 18;44(10):1029-38
pubmed: 21545096
PLoS One. 2018 Jun 11;13(6):e0198822
pubmed: 29889891
Arch Ophthalmol. 2005 Oct;123(10):1319-29
pubmed: 16219722
Am J Ophthalmol. 2014 Feb;157(2):349-54
pubmed: 24332375
Int J Biol Macromol. 2015 Jan;72:269-81
pubmed: 25020082
Pathol Biol (Paris). 2001 May;49(4):353-63
pubmed: 11428172
Nat Commun. 2020 Mar 18;11(1):1435
pubmed: 32188843

Auteurs

Mohammad Soleimani (M)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.

Zohreh Ebrahimi (Z)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Kosar Sadat Ebrahimi (KS)

Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Negin Farhadian (N)

Substance Abuse Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Mohsen Shahlaei (M)

Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Kasra Cheraqpour (K)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Hamed Ghasemi (H)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Sajad Moradi (S)

Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Arthur Y Chang (AY)

Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.

Sina Sharifi (S)

Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.

Seyed Mahbod Baharnoori (SM)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.

Ali R Djalilian (AR)

Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH